Rennova Health, Inc. (RNVA) Stock Price, Quote & News - Stock Analysis (2024)

FAQs

Is RNVa a good stock to buy? ›

Overall, Rennova Health Inc stock has a Growth Grade of D, Momentum Grade of A . Whether or not you should buy Rennova Health Inc stock will ultimately depend on your individual goals, risk tolerance and allocation. AAII can help you figure these out and identify which investments align with what works best for you.

FOXO Technologies has announced share exchange agreements to acquire healthcare operations from Rennova Health, including a critical access hospital and a behavioral health services subsidiary in the US.

Rennova Health, Inc. is a vertically integrated Public Company that provides industry leading Diagnostics and supportive software solutions to healthcare providers.

Is REAL a Buy, Sell or Hold? RealReal has a consensus rating of Moderate Buy which is based on 2 buy ratings, 3 hold ratings and 0 sell ratings. The average price target for RealReal is $3.73. This is based on 5 Wall Streets Analysts 12-month price targets, issued in the past 3 months.

Like other stocks, RNVA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker.

What Happened: FOXO Technologies said it entered into two share exchange agreements with Rennova on June 10th. Under the first agreement, equity in Myrtle Recovery Centers will be exchanged for $500,000 of common stock in FOXO. Myrtle Recovery Centers is a subsidiary of Rennova and provides behavioral health services.

The common shares of Emerald ("Emerald Shares") held by broker dealers will be automatically exchanged for 1.95 shares of Skye, as per the plan of arrangement agreed to between the companies on May 11, 2022, as amended.

Number of shares outstanding as of September 2024 : 2,406,800,000. According to Johnson & Johnson's latest financial reports and stock price the company's current number of shares outstanding is 2,406,800,000. At the end of 2024 the company had 2,406,800,000 shares outstanding.

How many shares does Humana have? ›

According to Humana's latest financial reports and stock price the company's current number of shares outstanding is 120,978,000.

According to Cigna's latest financial reports and stock price the company's current number of shares outstanding is 281,133,000. At the end of 2024 the company had 281,133,000 shares outstanding.

Smart healthcare refers to the use of technologies, such as IoT, big data, AI, and ML, to improve the quality and efficiency of healthcare delivery.

As a leading telehealth technology vendor, we provide the best and most up-to-date technology to help our clients: Increase patient engagement through education, automated reminders, and virtual visits. Improve clinical outcomes by providing a touch-point between and after in-person visits.

How many employees does AllCare Health have currently? As of July 2024, AllCare Health has approximately 246 employees across 2 continents, including North AmericaEurope. Key team members include Chief Executive Officer: M. J.Chief Marketing And Innovation Officer: F. S.Chief Financial Officer: M. W..

General Motors's analyst rating consensus is a Moderate Buy. This is based on the ratings of 16 Wall Streets Analysts.

Taylor Wimpey has 4.55% upside potential, based on the analysts' average price target. Is Taylor Wimpey a Buy, Sell or Hold? Taylor Wimpey has a consensus rating of Moderate Buy, which is based on 3 buy ratings, 2 hold ratings and 0 sell ratings. The average share price target for Taylor Wimpey is 163.25p.

O'Reilly Auto's analyst rating consensus is a Strong Buy. This is based on the ratings of 14 Wall Streets Analysts.

Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRM is experiencing buying pressure, which is a positive indicator for future bullish movement.